Korro Bio, Inc. Debt Securities, Available-for-sale, Noncurrent
Korro Bio, Inc. (KRRO) had Debt Securities, Available-for-sale, Noncurrent of $0 as of 2022-12-31, per its 10-K filed 2023-03-10.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent · last filed 2023-03-10
- 2022-12-31: Debt Securities, Available-for-sale, Noncurrent $0.00.
- 2022-09-30: Debt Securities, Available-for-sale, Noncurrent $0.00.
- 2022-03-31: Debt Securities, Available-for-sale, Noncurrent $7.41M.
- 2021-12-31: Debt Securities, Available-for-sale, Noncurrent $11.72M.
| Period end | Debt Securities, Available-for-sale, Noncurrent |
|---|---|
| 2022-12-31 | $0.00 10-K · filed 2023-03-10 |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-08 |
| 2022-03-31 | $7.41M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $11.72M 10-K · filed 2023-03-10 |
| 2021-09-30 | $12.40M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $6.63M 10-Q · filed 2021-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |